Baudax Bio, Inc. (BXRXQ) Financials
Stock symbol BXRXQ is outdated, potentially delisted? Maybe it is available on other exchange?
BXRXQ Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 20.6 million | 30.8 million |
| June 30, 2023 | 21.3 million | 32.0 million |
| March 31, 2023 | 7.1 million | 14.4 million |
| Dec. 31, 2022 | 10.0 million | 34.3 million |
BXRXQ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -2.4 million | 253000 |
| June 30, 2023 | -3.4 million | 198000 |
| March 31, 2023 | -4.7 million | 191000 |
| Dec. 31, 2022 | -3.8 million | 229000 |
BXRXQ Net Income
No data available :(
BXRXQ Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 363000 | - | 2.9 million |
| June 30, 2023 | 1.4 million | - | 2.9 million |
| March 31, 2023 | 3.8 million | 1.4 million | - |
| Dec. 31, 2022 | 5.3 million | 1.5 million | - |
BXRXQ Shares Outstanding
BXRXQ Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | 21000 | 1.7 million | 3.6 million | - |
| June 30, 2023 | - | 1.7 million | 2.3 million | - |
| March 31, 2023 | - | 2.9 million | 1.8 million | - |
| Dec. 31, 2022 | - | 1.0 million | 2.1 million | - |
BXRXQ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | - | 193000 |
| June 30, 2023 | - | 50000 |
| March 31, 2023 | - | 3000 |
| Dec. 31, 2022 | 310000 | 4.8 million |
BXRXQ
Price: $0
52 week price:
Earnings Per Share: -941.30 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 4359